H-1B sponsorship profile: Splint Pharma LLC. Across U.S. Department of Labor LCA disclosures, Splint Pharma LLC filed 111 Labor Condition Applications covering 167 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 97.3% (108 certified of 111 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Splint Pharma LLC’s H-1B petitions range from $60,000 at the low end to $111,072 at the high end, with a petition-weighted average of $84,692. That range reflects the mix of occupations the company sponsors, led by MANUFACTURING ENGINEER (9 petitions at $90,050 avg), followed by FORMULATION SCIENTIST and REGULATORY AFFAIRS SPECIALIST. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Splint Pharma LLC is headquartered in NEW YORK, NY under NAICS code 5416, and places H-1B workers across 18 states, most heavily in NY, TX, CA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Splint Pharma LLC ranks. By H-1B petition volume, Splint Pharma LLC is #2,001 of 119,880 employers nationally and #175 of 14,719 employers headquartered in NY. Both ranks are computed live from the same underlying petition counts, not a separate estimate.